Resource Logo
NLM AIDSLINE

The new generation of recombinant viral subunit vaccines.




 

Curr Opin Biotechnol. 1996 Dec;7(6):646-52. Unique Identifier : AIDSLINE

There have been two major focal points for the development of recombinant viral subunit vaccines. Expression strategies for the candidate antigens have focused increasingly on producing more natural antigenic structures, for example, virus-like particles. Also, new adjuvants have been used in order to increase immunogenicity.

Animal Antigens, Viral/GENETICS/IMMUNOLOGY Cytomegalovirus/GENETICS/IMMUNOLOGY Dengue Virus/GENETICS/IMMUNOLOGY Drug Design Hepatitis B Virus/GENETICS/IMMUNOLOGY Hepatitis C-Like Viruses/GENETICS/IMMUNOLOGY Herpesvirus 4, Human/GENETICS/IMMUNOLOGY Human HIV/GENETICS/IMMUNOLOGY Orthomyxoviridae/GENETICS/IMMUNOLOGY Papillomavirus, Human/GENETICS/IMMUNOLOGY Respiratory Syncytial Viruses/GENETICS/IMMUNOLOGY Rotavirus/GENETICS/IMMUNOLOGY Simplexvirus/GENETICS/IMMUNOLOGY Vaccines, Synthetic/*GENETICS/*IMMUNOLOGY Viral Vaccines/*GENETICS/*IMMUNOLOGY JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL



 




Information in this article was accurate in March 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.